Investigations were undertaken to characterize the protective immunity induced by porin-lipopolysaccharide (LPS) against SalmoneUla typhimurium infection in mice. Mice immunized with porin-LPS showed higher levels of antiporin immunoglobulin G than mice which received porin alone. Further, T cells from porin-LPSimmunized mice showed an augmented proliferative response to porin in vitro compared with the response of T cells from porin-injected animals. The passive transfer of anti-LPS antibodies conferred significant protection (17%), while antiporin serum failed to protect mice against lethal challenge, indicating the protective ability of anti-LPS antibodies. However, the transfer of serum obtained from porin-LPS-immunized mice resulted in better protection (30%o) than did anti-LPS or antiporin antibodies alone. In contrast to LPS, monophosphoryl lipid A completely failed to induce protection against lethal infection. However, comparable to the effect of LPS, injection of porin with monophosphoryl lipid A enhanced antibody response and the protective ability of porin (81.25%). The transfer of T cells from porin-LPS-immunized mice provided higher levels of protection (47%) against lethal challenge than did T cells from porin-immunized mice (23%). The combination of T cells and serum from porin-immunized mice transferred 36% protection. However, a combination of T cells and serum from porin-LPS-immunized mice conferred the highest level of protection (92%), which was reflected by the number of survivors (100%/) in the porin-LPS-immunized group. These results demonstrate that besides the protective effect of anti-LPS antibodies, the ability of LPS to augment humoral and cell-mediated immune responses to porin confers effective protection against SalnoneUla infection.
Several studies have stressed the significance of proteins as protective antigens in murine salmonellosis (3, 17, 20, 31, 46) . Cell surface proteins and protease-sensitive culture supematant factor from Salmonella typhimurium were found to protect mice from lethal challenge (20, 31) . However, this supernatant factor was protective only if 0 antigens were present in the supernatant (32) . In another study, Plant et al. (33) have reported that protein-lipopolysaccharide (LPS) complex isolated from S. typhimurium was able to induce protective immunity in mice. Though LPS-free proteins extracted from rough mutants of S. typhimurium, Salmonella minnesota, and Salmonella dublin conferred protection against lethal salmonellosis, the protective ability of purified proteins was lower than that of the corresponding crude extracts, suggesting that LPS might play a significant role in inducing protective immunity (39) . Rabbit anti-O antibodies passively administered to mice significantly enhanced the clearance of S. typhimunium challenge (11) . Similarly, sera raised in rabbits against polysaccharide-protein conjugates having specificity to 0 antigens conferred protection upon transfer (40) . The protective ability of antibodies of the immunoglobulin M (IgM) isotype with specificity to the 0-antigenic determinant has been reported elsewhere (38) .
In addition to its ability to induce protective antibodies, LPS has been shown to be a powerful adjuvant capable of enhancing the immune response to many antigens (8) . LPS isolated from various gram-negative bacteria stimulated a 20-fold-greater antibody response to ovalbumin in rabbits than did the administration of antigen alone (9) . In addition to the in vivo effects, addition of LPS during the first 12 to 24 h of in vitro cultures of spleen cells in the presence of sheep erythrocytes (SRBC) remarkably enhanced the anti-SRBC response (28) . Chiller and Weigle (6) have reported that LPS can convert a tolerogenic regimen of deaggregated human gamma globulin into an immune stimulus. Further, the ability of LPS to induce a characteristic switch in antibody responses from IgM to IgG has also been reported previously (47) . Considerable evidence indicates that LPS is capable of potentiating a variety of manifestations of T-cellmediated immune responses (8) . LPS was found to enhance the delayed-type hypersensitivity response to SRBC (19) . Further, by using athymic nude mice, the requirement of T cells for the adjuvant action of LPS to enhance the antibody response to T-dependent antigens has been demonstrated elsewhere (25) .
Although LPS is a strong immunopotentiating agent for various protein antigens, its use as immunological adjuvant is precluded by the fact that LPSs are extremely toxic and pyrogenic for most animal species (34) . However, monophosphoryl lipid A (MPL), the nontoxic form of lipid A, has been shown to retain the biological activities of LPS, such as B-cell mitogenicity, adjuvancity, activation of macrophages, and induction of interferon synthesis (10) . The effect of MPL in enhancing antibody response to SRBC (10) and ovalbumin (35) (42) .
There have been only limited attempts to understand the role of outer membrane proteins in inducing protective immunity against salmonellosis. Crude porin and crude outer membrane proteins prepared from the cell wall of S. typh-imurium protected mice against lethal challenge (18, 44) . Passive transfer of antiserum raised against purified porin did not protect mice, whereas antiserum obtained from mice immunized with LPS-reconstituted porin was protective (17) . Similarly, LPS-lipid A-associated protein complex but not LPS alone has been shown to protect mice against lethal Salmonella infection (14). Porin isolated from S. typhimurium when injected along with LPS induced higher level of protection than did porin or LPS alone (46) . Though the significance of LPS in the protective immunity against S. typhimurium is evident from these studies (17, 46) , it is not clear whether it is due mainly to anti-LPS antibodies or also to the augmentation of immune responses to porin by LPS. Therefore, the present study was aimed to characterize the enhanced protective immunity induced by porin-LPS and to test the efficacy of porin-MPL in the protection against S. typhimurium infection in mice.
MATERIALS AND METHODS
Mice. BALB/c mice of both sexes aged 6 to 10 weeks from our colony were used. They were fed with commercial feed (Hindustan Lever, Bombay, India) and water ad libitum.
Bacterial strain. A virulent strain of S. typhimurium C5
was obtained from C. E. Hormaeche, University of Cambridge, Cambridge, United Kingdom. This strain was used for isolation of porin as well as a challenge bacterium, and the 50% lethal dose (LD50) of C5 in BALB/c mice was 10 cells as reported and discussed earlier (43) . Briefly, the organisms used for challenge were grown in tryptic soy broth (Difco Laboratories, Detroit, Mich.), and for porin preparation, the bacteria were grown in nutrient broth containing peptone (1%), beef extract (1%), and NaCl (0.5% 2) were sonicated (Labline Ultratip; Labsonic System, Melrose Park, Ill.) and centrifuged at 80,000 x g for 30 min at 4°C. The cell wall pellet was suspended in 0.05 M Tris-HCl containing 2% (wt/vol) sodium dodecyl sulfate (SDS) and incubated overnight at 37°C. After centrifugation at 80,000 x g for 30 min at 20°C, the pellet obtained was treated with Tris-0.005 M EDTA and incubated for 2 h at 37°C. After further centrifugation as indicated in the previous step, porin was extracted in Tris-EDTA containing 0.2% SDS and 0.4 M NaCl. Porin was purified from this preparation by gel filtration in a Sepharose 6B column. Porin digested with an equal volume of sample buffer by heating at 100°C for 2 min was subjected to SDS-polyacrylamide (10%) gel electrophoresis followed by Coomassie blue (45) and LPS or MPL were tested for their ability to induce protection against lethal challenge. The dose which conferred maximum protection was selected as the optimal dose as reported earlier for porin and LPS (46) . Control mice received similar injections of either Tris buffer containing 0.2% SDS or 0.05% triethylamine in saline. Ten days after the last injection, animals were challenged intravenously (i.v.) with 10 LD50s of virulent S. typhimurium C5 in 0.2-ml volumes. The daily mortality was observed for up to 21 days postchallenge, and the percentage of survivors in each group was calculated at the end of this period.
Enumeration of bacteria in the spleen. The number of viable bacteria in the spleens of both control and experimental mice was determined as previously described (22) . The spleens were aseptically removed from mice at various time points and homogenized separately in 5-ml portions of sterile phosphate-buffered saline (PBS) with Teflon homogenizer. The cell suspension was serially diluted in PBS, and aliquots were plated in duplicate on MacConkey agar plates. The colonies were counted 24 h after incubation at 37°C. The calculation was made by assuming that each CFU represented a single bacterium.
Collection of sera. Control and immunized mice were bled retroorbitally with Pasteur pipettes. The sera were separated from the clot by centrifugation, inactivated at 57°C for 30 min, and stored at -20°C until use.
Determination of antibody levels. Antiporin or anti-LPS antibody titers were determined by enzyme-linked immunosorbent assay (ELISA) as described by Voller et al. (48) with a few modifications. Briefly, 96-well flat-bottom polystyrene plates (Immunoplate I; Nunc, Roskilde, Denmark) were coated with optimal concentrations of porin (0.5 ,g per well) or LPS (1.3 ,ug per well) dissolved in 0.05 M carbonatebicarbonate buffer (pH 9.6). Horseradish peroxidase-conjugated goat anti-mouse total or heavy-chain-specific immunoglobulins (Cappel, West Chester, Pa.) were used as probes to detect specific binding of mouse immunoglobulins. The substrate solution consisted of 0.04% O-phenylene diamine (Sigma) and 0.012% hydrogen peroxide in phosphate citrate buffer (pH 5). The log dilution of antibodies corresponding to an A490 of 0.15 was considered to be the titer. In some experiments antibody titers were expressed as ELISA titer units and were calculated as follows: total antibody titer/ 1,000 = number of units.
Purification ofT cells. The enriched T cells were purified as described in detail elsewhere (12) . Briefly, a single-cell suspension was prepared from inguinal lymph nodes or spleens in RPMI 1640 medium supplemented with 10% fetal calf serum. The cells were then washed three times and passed through a nylon wool column to remove adherent cells, and the T cells were eluted from the column with warm medium. The purity of T cells isolated was usually greater than 90%, as determined by complement-mediated lymphocytotoxicity (37) using anti-Thy 1.2 antibodies and guinea pig complement (Pel-Freez, Rogers, Ark.). For instance, the responses of isolated T cells from porin-LPS-immunized mice in the tests of purity with concanavalin A and LPS were 27,069 ± 2,672 and 3,624 t 234 cpm, respectively. The response to these mitogens was similar in cell preparations from other groups of mice.
Passive transfer of immune serum and cells. Control or immune serum (0.1 or 0.2 ml) was administered i.v. to naive animals 3 h prior to lethal challenge with S. typhimunium C5. The enriched splenic T cells (3 x 107) collected from control and immunized mice were transferred i.v. to naive mice. Mice were challenged i.v. with a lethal dose of C5 organisms 24 h later.
Proliferation assay. The enriched T cells isolated from control and immunized mice were cultured in RPMI 1640 medium containing 10% fetal calf serum by using 96-well flat-bottom microtiter plates. Cells were cultured for 5 days at a density of 2 x 10 per well and in a final volume of 0.2 ml at 37°C with 5% CO2. DNA synthesis was determined by addition of 0.5 ,uCi of [3H]thymidine (specific activity, 6.6 Ci/mol; Bhabha Atomic Research Center, Bombay, India) during the last 16 h of the culture period. Cultures were harvested onto glass fiber filters with a PHD cell harvester, and the radioactive counts were determined in a liquid scintillation counter (LKB, Bromma, Sweden).
Statistics. The data were expressed as arithmetic means + standard errors (SE). Two-tailed Student's t test was used to assess the significance of the data.
RESULTS
Effect of LPS on antiporin IgM and IgG responses. In order to characterize the protective immunity induced by porin-LPS, the qualitative and quantitative differences in the antiporin antibody responses were analyzed when porin was injected alone or with LPS. As shown in Fig. 1A , the antiporin IgM response was not enhanced by LPS. However, the magnitude of antiporin IgG response in porin-LPSimmunized mice was severalfold higher than that in the porin-immunized group, and the difference was highly significant (P < 0.0005), starting from the first week on (Fig.  1B) . The Analysis of protective ability of anti-porin-LPS serum. As indicated in Table 1 , the transfer of serum obtained from porin-immunized mice completely failed to give protection while serum collected from porin-LPS-immunized mice conferred 33% protection. Therefore, an attempt was made to understand whether the increased level of protection achieved by anti-porin-LPS serum was mediated by anti-LPS or antiporin antibodies. Serum obtained from mice immunized with porin-LPS showed 9 U of anti-LPS and 140.6 U of antiporin titers ( Table 2 ). This serum upon transfer protected 30% of the recipient mice, while anti-LPS serum (titer = 7.1 U) showed 17% protection. Both normal and antiporin sera (titer = 15 U) failed to confer protection. The transfer of antiporin serum obtained from mice immunized with porin emulsified in FCA also failed to confer protection, though it contained a high titer of antiporin antibodies (75.5 U). Notably, even the transfer of 0.1 ml of anti-porin-LPS sera gave 25% protection. These results showed that anti-LPS antibodies could protect mice but that the antibodies to pure porin could not. However, antibodies raised against porin-LPS were more protective, which could be due to an additive effect of anti-LPS antibodies plus the subclass of antiporin IgG generated as a result of immunization with porin-LPS. After secondary immunization, for the titers of antibodies shown in Table 2 , the proportion of antiporin IgM versus IgG titers in antiporin serum was 1:2.6 and in anti-porin-LPS serum was 1:24. The proportions of anti-LPS IgM versus IgG in anti-LPS and anti-porin-LPS sera were found to be 1:1.3 and 1:2.3, respectively (data not shown). Though 2.6-fold more antiporin IgG antibodies were detected after secondary immunization with porin alone, the proportion was dramatically lower than the level seen in porin-LPS-immunized mice (24-fold). Further, in addition to anti-LPS antibodies, the high antiporin IgG titer and the possible variations in the subclass of IgG generated in porin-LPS-immunized mice might have caused the enhanced level of protection.
Effect of LPS on proliferation of T cells responding to porin. To characterize whether injection of porin along with LPS influences the T-cell response to porin, the proliferative response of T cells in vitro was tested. Interestingly, the proliferative response of T cells from porin-LPS-immunized mice was found to be twofold higher than the response of T cells obtained from porin-immunized animals (Fig. 2) from the administration of porin-LPS occurred during the priming phase and that LPS can augment the proliferation of T cells which are responding to porin.
Effect of MPL on antibody response to porin. It was of interest to understand whether MPL, a detoxified form of LPS, could enhance the antibody response to porin. As shown in Table 3 , MPL markedly enhanced the antiporin antibody response. Fifteen days postimmunization, the antiporin titer in the porin-MPL-immunized group was significantly higher than the level seen in porin-immunized mice. The adjuvant effect of MPL on the antiporin antibody response was clearly evident after secondary immunization and was about fivefold higher than that in the porin-immunized group. The maximum increase in the antiporin response was seen in porin-LPS-immunized animals and was about ninefold higher than that of the porin-immunized group. These results indicated that MPL significantly enhanced the antibody response to porin. However, the adju- Effect of MPL on the protective ability of porin. Since MPL augmented the antibody response to porin, whether a similar effect in the level of protection was possible was tested.
Groups of mice were given two injections of MPL, LPS, porin, porin-MPL, and porin-LPS at 15-day intervals. Ten days after the last injection, mice were challenged lethally with Salmonella cells and protection was assessed. In contrast to mice which received LPS (35.7% survived), none of the mice immunized with MPL survived the lethal challenge, demonstrating that MPL was not a protective antigen (Table  4) . While all control animals died, immunization with porin resulted in 25% protection. On the other hand, administration of porin along with MPL significantly increased the survival rate to 81.25%, while porin-LPS induced a strong protective immunity, as evident by 100% survivors. These results indicate that MPL is capable of enhancing the protective immunity induced by porin but porin-LPS is a better candidate to induce complete protection.
In order to assess protective immunity more precisely, the in vivo growth pattern of challenge organisms was taken as another criterion. Mice injected with a combination of porin and MPL effectively controlled bacterial multiplication (Fig.  3) . However, the group of animals immunized with porin-LPS was more efficient in restricting the bacterial growth than any other group. Immunization with MPL alone completely failed to restrict the growth of challenge bacteria. In control and MPL-immunized mice, the challenge bacteria multiplied actively and resulted in death prior to 10 days. While 50 to 65% of the mice which received either porin or LPS also died in the first 10 days, the survivors in these groups began to control the growth of challenge organisms slowly. In contrast, mice immunized with porin-MPL or porin-LPS showed bacterial growth until day 6, and subsequently an effective restriction in the bacterial load was observed. These results demonstrate the development of an effective antibacterial mechanism in porin-MPL-immunized mice as well as in porin-LPS-immunized mice.
DISCUSSION
We have previously reported that porin in association with LPS evoked a higher level of protective immunity in mice against salmonellosis than either of these antigens alone (46) .
In the present study, an attempt was made to characterize the protective immunity induced by porin-LPS. The results shown in Fig. 1B indicate that porin in combination with LPS induced a profound antiporin IgG response compared with the response in mice which received porin alone. However, no such enhancement in the antiporin IgM response was observed (Fig. 1A) . Upon transfer, the serum collected from porin-LPS-immunized mice protected a higher percentage of mice than did anti-LPS or high-titer antiporin sera obtained with FCA ( in antiporin titer cannot be attributed to the enhanced protection observed in porin-LPS-immunized mice.
Administration of protein antigens along with FCA induced mostly antibodies of the IgGl subtype. On the other hand, immunization of the same antigen along with LPS preferentially evoked antibodies of the IgG3, IgG2b, and IgG2a subtypes (16) . Among murine antibodies, the IgG2a subtype is most effective in activating the complement and antibody-dependent cellular cytotoxicity mechanisms and mediating better protection against parasitic infections (49, 50) . Similarly, the protection against S. typhimurium infection by IgG3 monoclonal antibodies was demonstrated by Colwell et al. (7) . Recent results from our laboratory indicated a qualitative difference between antiporin antibodies generated as a result of immunization of porin along with LPS and FCA (23a). This qualitative difference in the antiporin antibody response might also be a reason for the differential protective ability of serum obtained from mice immunized with porin-LPS and porin emulsified in FCA.
The importance of anti-LPS antibodies in immunity to murine salmonellosis has been indicated by several workers (7, 15, 38, 40) . This importance was also evident from the present findings that passive transfer of anti-LPS serum provided better protection than did antiporin serum to the lethal challenge (Tables 1 and 2 ). However, anti-LPS antibodies did not seem to be the only factor in the enhanced level of protection induced by porin-LPS complex for two reasons: first, there was no significant enhancement in the anti-LPS titer above the level observed in LPS-immunized mice, and second, the passive transfer of anti-porin-LPS serum provided better protection than did anti-LPS serum alone ( Fig.  3 ). The increased level of protection induced by a combination of porin and MPL may be analogous to the situation in which porin injected along with Rb2 (rough) LPS protected mice against lethal challenge (46) . Further, Rb2 LPS was found to be as good as smooth LPS in improving the protective ability of porin (46) . However, unlike porin-LPS, immunization with porin-MPL did not result in complete protection ( Table 4 ), suggesting that anti-LPS antibodies play a significant role in protection against Salmonella infection. Therefore, it can be suggested that the increased level of protection observed in porin-LPS-immunized mice might be due to the combined effect of anti-LPS antibodies and the subclass of antiporin IgG generated as a result of immunization of porin along with LPS.
Previously, LPS been shown to potentiate a variety of manifestations of cell-mediated immune responses (19, 24, 30 The passive transfer of a combination of T cells and serum obtained from porin-LPS-immunized mice conferred 92% protection, and immunization of mice with porin-LPS resulted in complete protection against lethal challenge (Table  4 ). In contrast, a similar combination of T cells and serum from porin-immunized mice transferred only 36% protection (Table 1) , and correspondingly only a low level of protection (25%) was seen in mice which received porin alone (Table 4 ). Thus, the high level of protection seen in porin-LPS-immunized animals appears to be due to the augmentation of both humoral and T-cell-mediated immune responses to porin. Several adoptive transfer studies indicated that the protection against facultative intracellular bacteria depends on T-cell immunity (5, 13, 27) . The support mediated by specific T cells may be through macrophage activation and/or target cell lysis. In the present study, the adoptive transfer of a combination of immune serum and T cells into syngeneic mice considerably increased the level of protection against lethal challenge over that produced by either of these alone. Thus, defense mechanisms such as antibody-dependent bacteriolysis and phagocytosis might play a role, together with activation of macrophages for killing ingested salmonellae by soluble mediators such as gamma interferon secreted by T cells.
In the cell membrane, porin exists in the form of a complex with LPS (29) . The tightly bound nature of porin and LPS even after heat denaturation in the presence of SDS has been described by Rocque et al. (36) . Further, the porin-LPS complex in Escherichia coli was found to be necessary for phage T4 receptor activity (23) . These findings suggest the importance of porin-LPS interaction in performing their biological functions. It is possible that similar interaction with LPS enhances the immune potential of porin. In conclusion, besides generating protective anti-LPS antibodies, the ability of LPS to augment both humoral and cell-mediated immune responses to porin plays an important role in providing protection against Salmonella infection in mice.
